Prophylaxis for meningococcal disease.
D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002353:Carrier State / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy; D007223:Infant; D008585:Meningitis, Meningococcal / Q000517:prevention & control; D008589:Meningococcal Infections / Q000517:prevention & control* / Q000635:transmission; D008911:Minocycline / Q000627:therapeutic use; D009345:Neisseria meningitidis / Q000187:drug effects; D010400:Penicillin G / Q000627:therapeutic use; D010403:Penicillin Resistance; D012293:Rifampin / Q000627:therapeutic use; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use; D014481:United States
D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D008911:Minocycline; D010400:Penicillin G; D012293:Rifampin